Metraipolis › archive › dc_a5490caba1d9

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study — Europe PMC PMID:41820335

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41820335
DOI
10.1038/s41467-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-07T15:14:05.629Z
SHA-256 of the archived text
2f24ef893d91457609e567ebd59b313da44a6ce6cd46ad15549828942704f8a8
Stable URL of this page
https://metraipolis.com/documento/dc_a5490caba1d9

How to cite

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study — Europe PMC PMID:41820335 — Europe PMC (en), https://europepmc.org/article/MED/41820335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5490caba1d9 (Metraipolis archive dc_a5490caba1d9, sha256 2f24ef893d91457609e567ebd59b313da44a6ce6cd46ad15549828942704f8a8)
BibTeX
@misc{dca5490caba1d9,
  title = {Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study — Europe PMC PMID:41820335},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41820335},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5490caba1d9; sha256 2f24ef893d91457609e567ebd59b313da44a6ce6cd46ad15549828942704f8a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41820335. Agents can read the archived copy with the MCP tool read_document.